Assembly Biosciences, Inc. (ASMB)

NASDAQ: ASMB · IEX Real-Time Price · USD

13.48

+0.21 (1.58%)

At close: Apr 24, 2024, 12:14 PM

13.55

+0.07 (0.52%)

After-hours: Apr 24, 2024, 4:52 PM EDT

Assembly Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2008
Cash & Equivalents	19.84	52.42	45.63	59.44	46.73	41.47	82.03	28.58	27.11	29.09	Upgrade
Short-Term Investments	110.41	39.19	101	156.97	227.31	176.61	37.91	24.39	40.56	0	Upgrade
Cash & Cash Equivalents	130.25	91.61	146.63	216.41	274.04	218.08	119.95	52.96	67.66	29.09	Upgrade
Cash Growth	42.18%	-37.52%	-32.25%	-21.03%	25.66%	81.81%	126.47%	-21.73%	132.59%	7.50%	Upgrade
Receivables	0.04	0.94	0.34	1.23	3.37	2.43	2.27	0	0	0	Upgrade
Other Current Assets	3.5	4.41	7.24	6.85	5.36	1.99	0.9	0.61	0.7	0.13	Upgrade
Total Current Assets	133.79	96.97	154.2	224.49	282.78	222.5	123.12	53.57	68.37	29.22	Upgrade
Property, Plant & Equipment	2.72	3.94	7.18	10.73	13.81	0.56	0.86	0.21	0.15	0.16	Upgrade
Long-Term Investments	0	0	27.97	0	0	0	3.35	2.44	23.39	0	Upgrade
Goodwill and Intangibles	0	0	0	41.64	41.64	41.64	41.64	41.64	41.64	41.74	Upgrade
Other Long-Term Assets	0.31	0.89	1.7	6.39	1.68	3.35	0.34	0.26	0.2	0.12	Upgrade
Total Long-Term Assets	3.04	4.83	36.86	58.76	57.13	45.54	46.19	44.54	65.38	42.01	Upgrade
Total Assets	136.82	101.79	191.06	283.25	339.91	268.05	169.3	98.12	133.74	71.23	Upgrade
Accounts Payable	0.46	2.49	2.66	4.6	1.73	3.69	2.12	2.37	1.36	0.91	Upgrade
Deferred Revenue	86.29	2.73	2.73	8.99	37.05	40.66	45.79	0	0	0	Upgrade
Current Debt	1.22	3.36	3.15	3.4	3.19	0	0	0	0	0	Upgrade
Other Current Liabilities	-48.75	7.71	7.53	7.44	-17.53	-25.88	-34.42	4.75	2.04	0.15	Upgrade
Total Current Liabilities	39.23	16.3	16.07	24.43	24.44	18.47	13.49	7.12	3.4	1.05	Upgrade
Long-Term Debt	1.12	0.1	3.33	6.73	9.08	0	0	0	0	0	Upgrade
Other Long-Term Liabilities	55.38	2.73	2.73	11.52	33.17	38.92	42.69	11.12	11.6	11.6	Upgrade
Total Long-Term Liabilities	56.5	2.83	6.06	18.24	42.25	38.92	42.69	11.12	11.6	11.6	Upgrade
Total Liabilities	95.73	19.13	22.13	42.68	66.69	57.39	56.18	18.24	15	12.65	Upgrade
Total Debt	2.34	3.47	6.48	10.13	12.27	0	0	0	0	0	Upgrade
Debt Growth	-32.41%	-46.49%	-36.06%	-17.44%	-	-	-	-	-	-	Upgrade
Retained Earnings	-785.75	-724.52	-631.43	-501.57	-439.42	-341.79	-251.04	-208.23	-163.97	-135.51	Upgrade
Comprehensive Income	-0.08	-0.8	-0.42	-0.27	-0.2	-0.35	-0.39	-0.6	-0.82	0	Upgrade
Shareholders' Equity	41.1	82.66	168.93	240.58	273.22	210.65	113.12	79.88	118.74	58.57	Upgrade
Net Cash / Debt	127.91	88.15	140.15	206.28	261.78	218.08	119.95	52.96	67.66	29.09	Upgrade
Net Cash / Debt Growth	45.11%	-37.11%	-32.06%	-21.20%	20.04%	81.81%	126.47%	-21.73%	132.59%	7.50%	Upgrade
Net Cash Per Share	27.94	21.85	38.86	69.87	119.63	114.77	81.09	36.89	51.71	49.88	Upgrade
Working Capital	94.56	80.67	138.13	200.06	258.34	204.03	109.63	46.45	64.97	28.16	Upgrade
Book Value Per Share	8.98	20.49	46.84	81.49	124.86	110.86	76.47	55.64	90.74	100.42	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).